Table 3.
HRs (95% CIs) for death from CVD, non-CVD, and all causes for group II compared with group I
| Model 1 | Model 2 | Model 3 | |
|---|---|---|---|
| Men | |||
| n | 12,566 | 12,566 | 9,978 |
| CVD | 1.16 (1.01–1.34) | 1.22 (1.05–1.41) | 1.25 (1.05–1.50) |
| Non-CVD | 1.01 (0.86–1.19) | 1.09 (0.92–1.29) | 1.09 (0.89–1.34) |
| All causes | 1.10 (0.99–1.22) | 1.16 (1.04–1.30) | 1.18 (1.03–1.35) |
| Women | |||
| n | 10,874 | 10,874 | 7,350 |
| CVD | 1.23 (0.91–1.65) | 1.40 (1.03–1.89) | 1.60 (1.03–2.48) |
| Non-CVD | 0.92 (0.73–1.15) | 0.99 (0.79–1.25) | 1.05 (0.78–1.42) |
| All causes | 1.03 (0.86–1.23) | 1.13 (0.94–1.35) | 1.18 (0.93–1.51) |
Model 1: adjusted for age and cohort; model 2: model 1 plus fasting plasma glucose, BMI, total cholesterol, smoking and hypertension status; model 3: model 2 plus fasting insulin. Group I, 2-h plasma glucose ≤ FPG; group II, 2-h plasma glucose > FPG.